GILEAD SCIENCES, INC. — Director's Dealing 2018

Feb 2, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-01-31

Reporting Person: BARTON JACQUELINE K (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-31	Non-qualified Stock Option (Right to Buy)	$83.80	A	2119	Acquired	2028-01-31	Common Stock (2119)	Direct
2018-01-31	Restricted Stock Unit	$	A	480	Acquired		Common Stock (480)	Direct

Footnotes

F1: Options vest quarterly over the first year of service and will be fully vested on January 31, 2019.

F2: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3: 100% of the restricted stock units will vest on January 31, 2019 at the end of the first year of service.